KILITCHPharmaceuticals
Kilitch Drugs India Ltd — Cash Flow Statement
₹124.45
-9.06%
Kilitch Drugs India Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -29.33 Cr | -7.99 Cr | -1.23 Cr | -2.42 Cr | — |
| Issuance Of Debt | 17.78 Cr | 9.45 Cr | 1.76 Cr | 5.63 Cr | — |
| Issuance Of Capital Stock | 0.00 | 3.86 Cr | 2.50 Cr | 2.59 Cr | — |
| Capital Expenditure | -46.87 Cr | -6.45 Cr | -3.81 Cr | -8.20 Cr | — |
| End Cash Position | 9.80 Cr | 18.96 Cr | 19.85 Cr | 10.06 Cr | — |
| Beginning Cash Position | 18.96 Cr | 19.85 Cr | 10.06 Cr | 12.50 Cr | — |
| Changes In Cash | -9.16 Cr | -0.88 Cr | 9.78 Cr | -2.44 Cr | — |
| Financing Cash Flow | 13.24 Cr | 8.81 Cr | -0.72 Cr | 7.03 Cr | — |
| Net Other Financing Charges | 0.51 Cr | 1.43 Cr | -0.06 Cr | 0.01 Cr | — |
| Interest Paid Cff | -5.04 Cr | -5.93 Cr | -4.92 Cr | -1.20 Cr | — |
| Net Common Stock Issuance | 0.00 | 3.86 Cr | 2.50 Cr | 2.59 Cr | — |
| Common Stock Issuance | 0.00 | 3.86 Cr | 2.50 Cr | 2.59 Cr | — |
| Net Issuance Payments Of Debt | 17.78 Cr | 9.45 Cr | 1.76 Cr | 5.63 Cr | — |
| Net Long Term Debt Issuance | 17.78 Cr | 9.45 Cr | 1.76 Cr | 5.63 Cr | — |
| Long Term Debt Issuance | 17.78 Cr | 9.45 Cr | 1.76 Cr | 8.13 Cr | — |
| Investing Cash Flow | -39.95 Cr | -8.16 Cr | 7.92 Cr | -15.25 Cr | — |
| Net Other Investing Changes | 0.63 Cr | -0.54 Cr | -1000.00 | -0.37 Cr | — |
| Interest Received Cfi | 1.03 Cr | 0.40 Cr | 0.30 Cr | 0.22 Cr | — |
| Dividends Received Cfi | 55000.00 | 0.01 Cr | 87000.00 | 0.03 Cr | — |
| Net Investment Purchase And Sale | 5.27 Cr | -1.57 Cr | 11.42 Cr | -6.93 Cr | — |
| Purchase Of Investment | -75000.00 | -0.18 Cr | — | -6.93 Cr | -1.66 Cr |
| Capital Expenditure Reported | -46.87 Cr | -6.45 Cr | -3.81 Cr | -8.20 Cr | — |
| Operating Cash Flow | 17.54 Cr | -1.53 Cr | 2.59 Cr | 5.78 Cr | — |
| Taxes Refund Paid | -8.47 Cr | -7.04 Cr | -4.33 Cr | -2.54 Cr | — |
| Change In Working Capital | -9.63 Cr | -24.31 Cr | -14.88 Cr | -5.19 Cr | — |
| Change In Other Current Liabilities | 0.04 Cr | 0.03 Cr | -0.32 Cr | -0.83 Cr | — |
| Change In Other Current Assets | -4.32 Cr | 1.87 Cr | -0.50 Cr | -5.44 Cr | — |
| Change In Payable | 28.57 Cr | -12.29 Cr | -1.99 Cr | 22.71 Cr | — |
| Change In Prepaid Assets | -0.71 Cr | -0.09 Cr | -0.16 Cr | -0.02 Cr | — |
| Change In Inventory | -11.32 Cr | -1.94 Cr | 2.96 Cr | -1.41 Cr | — |
| Change In Receivables | -22.07 Cr | -11.92 Cr | -15.49 Cr | -20.30 Cr | — |
| Other Non Cash Items | 4.02 Cr | 5.52 Cr | 4.62 Cr | 0.98 Cr | — |
| Depreciation And Amortization | 3.11 Cr | 3.35 Cr | 3.55 Cr | 2.47 Cr | — |
| Depreciation | 3.11 Cr | 3.35 Cr | 3.55 Cr | 2.47 Cr | — |
| Pension And Employee Benefit Expense | 44000.00 | 50000.00 | 0.00 | 0.03 Cr | — |
| Gain Loss On Investment Securities | -6.53 Cr | -1.40 Cr | -1.00 Cr | -1.39 Cr | — |
| Net Foreign Currency Exchange Gain Loss | -0.60 Cr | -0.16 Cr | -0.53 Cr | 0.72 Cr | — |
| Net Income From Continuing Operations | 34.47 Cr | 19.35 Cr | 12.01 Cr | 9.61 Cr | — |
| Other Cash Adjustment Outside Changein Cash | — | 3000.00 | 100.00 | 1000.00 | — |
| Net Short Term Debt Issuance | — | 9.45 Cr | 1.76 Cr | 5.63 Cr | 2.19 Cr |
| Short Term Debt Issuance | — | 9.45 Cr | 1.76 Cr | 5.63 Cr | 2.19 Cr |
| Net PPE Purchase And Sale | — | -6.45 Cr | -3.81 Cr | -8.20 Cr | -36.30 Cr |
| Purchase Of PPE | — | -6.45 Cr | -3.81 Cr | -8.20 Cr | -36.30 Cr |
| Provisionand Write Offof Assets | — | 3.14 Cr | 3.14 Cr | — | — |
| Sale Of Investment | — | — | 9.43 Cr | 0.00 | 0.16 Cr |
| Cash Dividends Paid | — | — | — | -1.20 Cr | — |
| Stock Based Compensation | — | — | — | 0.00 | -0.16 Cr |
| Repayment Of Debt | — | — | — | — | -0.75 Cr |
| Long Term Debt Payments | — | — | — | — | -0.75 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Kilitch Drugs India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.